. Author manuscript; available in PMC: 2022 Oct 4.

Published in final edited form as: IEEE Trans Med Imaging. 2021 Nov 30;40(12):3748–3761. doi: 10.1109/TMI.2021.3097665

TABLE I.

Patient clinical and demographics at baseline (t0) and follow-up scan (T1).

A) Demographics
	Training (N=30)		Testing (N=70)
	Cancer (N=15)	Benign (N=15)	Cancer (N=35)	Benign (N=35)
Age (median/mean/st.dev)	62/64.3/5.1	66/64.2/5.3	66/65.6/4.92	66/65.6/5.22
Gender (M/F)	8/7	14/1	18/17	15/15
Race (White/African-American/Latino/Mixed)	15/0/0/0	15/0/0/0	34/1	34/1
Clinical Stage & Grade (# in: Well/Moderate/Poor/Undifferentiated/Unspecified)
1A	10 (2/4/3/0/1)	0	17 (3/9/3/1/1)	0
1B	0	0	7 (1/3/2/1/0)	0
IIA	2 (0/1/1/0/0)	0	2 (0/2/0/0/0)	0
IIB	0	0	2 (0/1/1/0/0)	0
IIIA	1 (0/0/0/0/1)	0	0	0
IIIB	1 (0/0/0/0/1)	0	3 (0/0/0/0/3)	0
IV	1 (0/0/0/0/1)	0	4 (0/0/0/1/2)	0
N/A	0	15	0	35